Perspectives on Biosimilars

Media formats available:

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

The Future of IBD Therapy: Expert Perspectives on Biosimilars
The Future of IBD Therapy: Expert Perspectives on Biosimilars
Medical Therapy
The Future of IBD Therapy: Expert Perspectives on Biosimilars
- Alan C. Moss, MD, FACG, FEBG, AGAF, FRCPI
- Ross M. Maltz, MD
- Melissa Kirkpatrick, PharmD, BCACP
Pathogenesis of IBD
Pathogenesis of IBD
Medical Therapy
Pathogenesis of IBD
- Michele Rubin, APN, CNS, CGRN
Medical Therapies in IBD: Parts 1 & 2
Medical Therapies in IBD: Parts 1 & 2
Medical Therapy
Medical Therapies in IBD: Parts 1 & 2
- Jenny S. Sauk, MD
Scripps Conference: New Advances in Inflammatory Bowel Disease
Case Presentation: Inpatient IBD – My Approach to Management of Intra-Abdominal Abscesses
Scripps Conference: New Advances in Inflammatory Bowel Disease
Case Presentation: Inpatient IBD – My Approach to Management of Intra-Abdominal Abscesses
Medical Therapy
Scripps Conference: New Advances in Inflammatory Bowel Disease
Case Presentation: Inpatient IBD – My Approach to Management of Intra-Abdominal Abscesses
- Benjamin L. Cohen, MD